• Bacigalupo, A., Van Lint, M.T., Occhini, D., Gualandi, F., Lamparelli, T., Sogno, G., Tedone, E., Frassoni, F., Tong, J. & Marmont, A.M. (1991) Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood, 77, 14231428.
  • Bainbridge, D.R. & Macey, M.G. (1983) Hoechst 33258, a fluorescent nuclear counterstain suitable for double-labelling immunofluorescence. Journal of Immunological Methods, 62, 193195.
  • Barnes, D.W.H., Corp, M.J., Loutit, J.F. & Neal, F.E. (1956) Treatment of murine leukaemia with X-rays and homologous bone marrow. British Medical Journal, 2, 626.
  • Bennett, J.M., Catovsky, D., Daniel, M.-T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1976) Proposals for the classification of the acute leukaemias. British Journal of Haematology, 33, 451458.
  • Cebrian, M., Yague, E., Rincon, M., Lopez-Botet, M., De Landazuri, M.O. & Sanchez-Madrid, F. (1988) Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. Journal of Experimental Medicine, 168, 16211637.
  • Chambers, W.H., Vujanovic, N.L., DeLeo, A.B., Olszowy, M.W., Herberman, R.B. & Hiserodt, J.C. (1989) Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. Journal of Experimental Medicine, 169, 13731389.
  • Craston, R., Koh, M., McDernott, A., Ray, N., Prentice, H.G. & Lowdell, M.W. (1997) Temporal dynamics of CD69 expression on lymphoid cells. Journal of Immunological Methods, 209, 3745.DOI: 10.1016/S0022-1759(97)00143-9
  • Deane, M., Koh, M., Foroni, L., Galactowicz, G., Hoffbrand, A.V., Lawler, M., Secker-Walker, L. & Prentice, H.G. (1998) FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission. Bone Marrow Transplantation, 22, 11371143.
  • Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.-J., Rimm, A.A., Ringden, O., Rozman, C., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555562.
  • Kaplan, E. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kolb, H.-J., Mittermueller, J., Clemm, C., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 24622465.
  • Lanier, L.L., Buck, D.W., Rhodes, L., Ding, A., Evans, E., Barney, C. & Phillips, J.H. (1988) Interleukin-2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu 23 activation antigen. Journal of Experimental Medicine, 167, 15721585.
  • Lanier, L.L., Chang, C. & Phillips, J.H. (1994) Human NKR-P1A: a disulphide linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. Journal of Immunology, 153, 24172428.
  • Lehman, C., Zeis, M., Schmitz, N. & Uharek, L. (2000) Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells. Blood, 96, 594600.
  • Lowdell, M.W., Ray, N., Craston, R., Corbett, T., Deane, M. & Prentice, H.G. (1997) The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia. Bone Marrow Transplantation, 19, 891897.
  • Lowdell, M.W., Craston, R. & Prentice, H.G. (1999) Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment. Cytokines, Cellular and Molecular Therapy, 5, 119121.
  • Molldrem, J.J., Lee, P.P., Wang, C., Felio, K., Kantarjian, H.M., Champlin, R.E. & Davis, M.M. (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukaemia. Nature Medicine, 6, 10181023.DOI: 10.1038/79526
  • Robertson, L.E., Denny, A.W., Huh, Y.O., Plunkett, W., Keating, M.J. & Nelson, J.A. (1996) Natural killer cell activity in chronic lymphocytic leukaemia patients treated with fludarabine. Cancer Chemotherapy and Pharmacology, 37, 445450.DOI: 10.1007/s002800050410
  • Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Kapelushnik, J. & Or, R. (1995) Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Experimental Hematology, 23, 15531562.
  • Tratkiewicz, J.A. & Szer, J. (1990) Loss of natural killer activity as an indicator of relapse in acute leukaemia. Clinical Experimental Immunology 1990, 80, 241246.
  • Vaughan, W.P., Karp, J.E. & Burke, P.J. (1980) Long chemotherapy-free remissions after single-cycle timed-sequential chemotherapy for acute myelocytic leukaemia. Cancer, 45, 859865.